Imunon, Inc. Amortization of Other Deferred Charges
Imunon, Inc. (IMNN) reported Amortization of Other Deferred Charges of -$13.75 thousand for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherAmortizationOfDeferredCharges · last filed 2013-11-12
- Imunon, Inc. amortization of other deferred charges for the quarter ending 2013-09-30 was -$5.19K.
- Imunon, Inc. amortization of other deferred charges for the quarter ending 2013-06-30 was -$4.73K.
- Imunon, Inc. amortization of other deferred charges for the quarter ending 2013-03-31 was -$3.83K, a 105.85% decline year-over-year.
- Imunon, Inc. amortization of other deferred charges for the quarter ending 2012-09-30 was -$3.83K.
- Imunon, Inc. amortization of other deferred charges for fiscal 2011 was $65.47K.
- Imunon, Inc. amortization of other deferred charges for fiscal 2010 was $0.00.
| Period end | Amortization of Other Deferred Charges 3 month | Amortization of Other Deferred Charges 6 month | Amortization of Other Deferred Charges 9 month | Amortization of Other Deferred Charges 12 month |
|---|---|---|---|---|
| 2013-09-30 | -$5.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$9.92K derived: sum of 2 quarters · filed 2013-11-12 | -$13.75K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | -$4.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$8.56K 10-Q · filed 2013-08-08 | ||
| 2013-03-31 | -$3.83K 10-Q · filed 2013-05-09 | |||
| 2012-09-30 | -$3.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$6.38K derived: sum of 2 quarters · filed 2013-11-12 | $59.09K 10-Q · filed 2013-11-12 | |
| 2012-06-30 | -$2.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $62.91K 10-Q · filed 2013-08-08 | ||
| 2012-03-31 | $65.47K 10-Q · filed 2013-05-09 | |||
| 2011-12-31 | $65.47K 10-K/A · filed 2012-03-15 | |||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-15 | |||
| 2010-12-31 | $0.00 10-K/A · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |